BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34060130)

  • 21. A case of primary cutaneous extranodal natural killer/t-cell lymphoma, nasal type, with a 22-year indolent clinical course.
    Zuriel D; Fink-Puches R; Cerroni L
    Am J Dermatopathol; 2012 Apr; 34(2):194-7. PubMed ID: 22172956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extranodal natural killer/T-cell lymphoma, nasal type in Taiwan: a relatively higher frequency of T-cell lineage and poor survival for extranasal tumors.
    Jhuang JY; Chang ST; Weng SF; Pan ST; Chu PY; Hsieh PP; Wei CH; Chou SC; Koo CL; Chen CJ; Hsu JD; Chuang SS
    Hum Pathol; 2015 Feb; 46(2):313-21. PubMed ID: 25554090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus-positive nodal T/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features.
    Jeon YK; Kim JH; Sung JY; Han JH; Ko YH;
    Hum Pathol; 2015 Jul; 46(7):981-90. PubMed ID: 25907865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic nutritional index predicts survival for patients with extranodal natural killer/T cell lymphoma, nasal type.
    Chen KL; Liu YH; Li WY; Chen J; Gu YK; Geng QR; Jiang WQ; Huang HQ; Lin TY; Xia ZJ; Cai QQ
    Ann Hematol; 2015 Aug; 94(8):1389-400. PubMed ID: 25869028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors and treatment outcomes for patients with stage II extranodal nasal-type natural killer/T-cell lymphoma of the upper aerodigestive tract.
    Fang H; Jin J; Wang WH; Wang SL; Zhou LQ; Li YX
    Leuk Lymphoma; 2014 Aug; 55(8):1832-7. PubMed ID: 24144309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis.
    Kim SJ; Yoon DH; Jaccard A; Chng WJ; Lim ST; Hong H; Park Y; Chang KM; Maeda Y; Ishida F; Shin DY; Kim JS; Jeong SH; Yang DH; Jo JC; Lee GW; Choi CW; Lee WS; Chen TY; Kim K; Jung SH; Murayama T; Oki Y; Advani R; d'Amore F; Schmitz N; Suh C; Suzuki R; Kwong YL; Lin TY; Kim WS
    Lancet Oncol; 2016 Mar; 17(3):389-400. PubMed ID: 26873565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The extent of cutaneous lesions predicts outcome in extranodal nasal-type natural killer/T-cell lymphoma of the upper aerodigestive tract with secondary cutaneous involvement.
    Qi SN; Li YX; Wang WH; Jin J; Wang SL; Liu YP; Song YW; Fang H; Ren H; Lu NN; Liu QF; Wu RY; Zhang XM; Liu XF; Yu ZH
    Leuk Lymphoma; 2012 May; 53(5):855-61. PubMed ID: 22035375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secondary cutaneous lymphoma: comparative clinical features and survival outcome analysis of 106 cases according to lymphoma cell lineage.
    Lee WJ; Won KH; Won CH; Chang SE; Choi JH; Moon KC; Park CS; Huh J; Suh C; Lee MW
    Br J Dermatol; 2015 Jul; 173(1):134-45. PubMed ID: 25556641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of Epstein-Barr virus-encoded RNA expression in cutaneous dissemination of natural killer/T-cell lymphoma.
    Teo WL; Tan SY
    J Clin Oncol; 2011 Apr; 29(12):e342-3. PubMed ID: 21282547
    [No Abstract]   [Full Text] [Related]  

  • 30. [Characteristics of primary cutaneous rare nasal extranodal NK/T cell lymphoma: a clinicopathological study of 15 cases].
    Zhao WG; Zhao HY; Wang GN; Zhang DD; Zhang YP; Zhao HB; Zhang CL; Zhang M; Li WC
    Zhonghua Bing Li Xue Za Zhi; 2021 Jun; 50(6):609-614. PubMed ID: 34078048
    [No Abstract]   [Full Text] [Related]  

  • 31. Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients.
    Massone C; Chott A; Metze D; Kerl K; Citarella L; Vale E; Kerl H; Cerroni L
    Am J Surg Pathol; 2004 Jun; 28(6):719-35. PubMed ID: 15166664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and management of extranodal NK/T cell lymphoma nasal type.
    Tse E; Kwong YL
    Expert Rev Hematol; 2016 Sep; 9(9):861-71. PubMed ID: 27347812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer.
    Assaf C; Gellrich S; Whittaker S; Robson A; Cerroni L; Massone C; Kerl H; Rose C; Chott A; Chimenti S; Hallermann C; Petrella T; Wechsler J; Bagot M; Hummel M; Bullani-Kerl K; Bekkenk MW; Kempf W; Meijer CJ; Willemze R; Sterry W
    J Clin Pathol; 2007 Sep; 60(9):981-9. PubMed ID: 17018683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD56+ lymphoma with skin involvement: clinicopathologic features and classification.
    Gniadecki R; Rossen K; Ralfkier E; Thomsen K; Skovgaard GL; Jønsson V
    Arch Dermatol; 2004 Apr; 140(4):427-36. PubMed ID: 15096371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary spinal natural killer/T-cell lymphoma successfully treated with concurrent chemoradiotherapy and autologous stem cell transplantation.
    Kim KT; Kim YB; Kim HJ; Cha YJ; Lee SJ; Park E
    Spine (Phila Pa 1976); 2012 May; 37(10):E629-32. PubMed ID: 22089400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics and survival of extranodal natural killer/T-cell lymphoma: a single-center 12-year retrospective analysis.
    Chen Y; Luo L; Zheng X; Fu H; Yang X; Huang W; Chen L; Zheng Z; Zheng J; Yang T; Liu T; Hu J
    Leuk Lymphoma; 2020 Dec; 61(14):3306-3318. PubMed ID: 32820684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma.
    Niu SQ; Yang Y; Li YY; Wen G; Wang L; Li ZM; Wang HY; Zhang LL; Xia YF; Zhang YJ
    Chin J Cancer; 2016 Apr; 35():34. PubMed ID: 27044275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the immune microenvironment in the indolent form of primary cutaneous extranodal natural killer/T-cell lymphoma: A case report.
    Maeda R; Minowa T; Kato J; Horimoto K; Sato S; Hirohashi Y; Torigoe T; Uhara H
    J Dermatol; 2024 Apr; 51(4):e137-e138. PubMed ID: 37997464
    [No Abstract]   [Full Text] [Related]  

  • 39. [Extranodal Natural Killer/T-Cell Lymphoma, nasal-type with primary cutaneous involvement. A case report].
    Silva-Feistner M; Rojas-Lechuga MJ; Ortiz E; Molgó M
    Rev Chil Pediatr; 2018 Apr; 89(2):246-250. PubMed ID: 29799894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extranodal natural killer/T-Cell lymphoma: A population-based comparison of sinonasal and extranasal disease.
    Vazquez A; Khan MN; Blake DM; Sanghvi S; Baredes S; Eloy JA
    Laryngoscope; 2014 Apr; 124(4):888-95. PubMed ID: 24114591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.